Ditchcarbon
  • Contact
  1. Organizations
  2. Genscript Biotech Corporation
Public Profile
Research Services
CN
updated 2 months ago

Genscript Biotech Corporation Sustainability Profile

Company website

Genscript Biotech Corporation, a leading player in the biotechnology industry, is headquartered in China (CN) and operates extensively across North America, Europe, and Asia. Founded in 2002, Genscript has established itself as a pioneer in gene synthesis, peptide synthesis, and antibody development, catering to a diverse range of sectors including pharmaceuticals, diagnostics, and academic research. The company’s core offerings, such as its innovative gene editing tools and custom protein services, are distinguished by their high quality and rapid turnaround times. Genscript's commitment to advancing life sciences has earned it a prominent market position, with notable achievements including numerous collaborations with top-tier research institutions and a robust portfolio of intellectual property. As a trusted partner in biotechnological advancements, Genscript continues to drive innovation and support scientific discovery globally.

DitchCarbon Score

How does Genscript Biotech Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

57

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Genscript Biotech Corporation's score of 57 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

Let us know if this data was useful to you

Genscript Biotech Corporation's reported carbon emissions

In 2024, Genscript Biotech Corporation reported total greenhouse gas emissions of approximately 39376800 kg CO2e for Scope 1, 114034820 kg CO2e for Scope 2 (market-based), and 387589810 kg CO2e for Scope 3 emissions. This reflects a significant commitment to reducing their carbon footprint, with a total of about 153411610 kg CO2e for combined Scope 1 and 2 emissions (market-based). Genscript has set ambitious reduction targets as part of its climate commitments. The company aims to achieve a 54.6% reduction in absolute Scope 1 and 2 emissions by 2033, using 2023 as the base year. Additionally, they plan to reduce Scope 3 emissions by 32.5% within the same timeframe. Long-term goals include a 90% reduction in both Scope 1 and 2 emissions by 2050, as well as a 90% reduction in Scope 3 emissions. Furthermore, Genscript is committed to ensuring that 83% of its suppliers, based on emissions from purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2029. The company has pledged to reach net-zero greenhouse gas emissions across its value chain by 2050, aligning with industry standards for climate action. This data is sourced directly from Genscript Biotech Corporation, with no cascading from a parent organization.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
48,821,780
00,000,000
Scope 2
83,758,360
000,000,000
Scope 3
314,658,760
000,000,000

How Carbon Intensive is Genscript Biotech Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genscript Biotech Corporation's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Genscript Biotech Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genscript Biotech Corporation is in CN, which we do not have grid emissions data for.

Genscript Biotech Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Genscript Biotech Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Genscript Biotech Corporation's Emissions with Industry Peers

Millipore

US
•
Chemicals nec
Updated 3 days ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 11 days ago

Promega

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Zymeworks Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Aldevron, LLC

US
•
Research and development services (73)
Updated 28 days ago

Sigma-Aldrich Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy